Bellerophon Therapeutics, Inc. Annual Return On Equity in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2022.
  • Bellerophon Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -165 %, a 24% decline year-over-year.
  • Bellerophon Therapeutics, Inc. annual Return On Equity for 2022 was -207 %, a 222% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Return On Equity for 2021 was -64.2 %, a 9.35% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Return On Equity for 2020 was -70.8 %, a 56.4% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -207 -142 -222% Jan 1, 2022 Dec 31, 2022
2021 -64.2 +6.62 +9.35% Jan 1, 2021 Dec 31, 2021
2020 -70.8 +91.4 +56.4% Jan 1, 2020 Dec 31, 2020
2019 -162 -668 -132% Jan 1, 2019 Dec 31, 2019
2018 506 +2.18K Jan 1, 2018 Dec 31, 2018
2017 -1.67K -1.56K -1306% Jan 1, 2017 Dec 31, 2017
2016 -119 -18.4 -18.3% Jan 1, 2016 Dec 31, 2016
2015 -101 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.